Acting Editor-in-Chief
Shanker Gupta, PhD
Dr. Shanker Gupta has stepped up to take on the role of Acting Editor-in-Chief while PDA conducts the search for a permanent Editor. Richard V. Levy, PhD, retired as Editor-in-Chief of the PDA Journal of Pharmaceutical Science and Technology (JPST) after almost four years as its head. Gupta has been a member of the Journal Editorial Board since 2019 and, most recently, has served as an Associate Editor, helping evaluating and managing JPST submissions. He has been a PDA member for more than 30 years.
Gupta has worked with the National Institutes of Health for almost 20 years, currently as a senior scientist in the Division of Cancer Prevention of the National Cancer Institute and consulting with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases. At NIH, he has been responsible for managing multiple translational projects designed to generate clinical product for use in Phase I and Phase 2 clinical trials. Gupta also collaborates with contract teams and actively participates in the design and development of formulations of several promising agents that have resulted in patent filings. He has supported over 40 IND submissions.
Gupta holds a BS (Hons) in pharmacy from the University of Florida and a PhD in pharmaceutical chemistry from the University of Michigan, Ann Arbor. Prior to joining NIH, he was a project leader in sterile products development at Abbott Laboratories and filed the IND for the expanded use of a lung surfactant product (Survanta®), which was the first product of its kind for neonatal respiratory distress syndrome. Gupta has published more than 20 papers in various peer-reviewed journals and contributed to books.
Associate Editors
|
Michael (Mike) Sadowski, Baxter Healthcare Corporation |
|
Editorial Board
|
James Akers, PhD, Akers Kennedy & Associates
|
|
|
|
H. Gregg Claycamp, PhD, Consultant (U.S. FDA, retired)
|
|
|
|
|
|
Ankur K lshrestha, PhD, Bristol Myers Squibb |
|
|
Richard V. Levy, PhD, PDA (ret.)  |
|
|
H anns-Christian Mahler, PhD, ten23 health AG |
|
Murali Muralidhara, PhD, RVAC Medicines
|
Neha Pardeshi, PhD, Amgen
|
|
|
.
|
 Wendy R. Saffell-Clemmer, MS, Baxter International Inc. |
Tim Sandle, PhD, Bio Products Laboratory Limited
|
|
Alicja Sobantka , PhD, Octapharma
|
|
|
|
|
|
Kelly Waldron, PhD, ValSource Inc. |
 Wesley Workman, PhD, Workman Biotech Consultants, LLC
|
|
|
|
|
|
|
|
Daniele Zuccato, MS, SCHOTT Pharma |
Jose Caraballo, MBA/ME, Kite Pharma, a Gilead Company
Dayue Chen, PhD, Genentech, a Member of the Roche Group
Tony Cundell, PhD, 
Fenton Fong, MSc, xCellarate Technology Consulting Inc.
Kelvin Lee, PhD, NIIMBL
Duncan Low, PhD, Claymore Biopharm LLC 
Jai Pathak, PhD, AztraZeneca
István Szikora, MBA/MS, Novartis
Edward C. Tidswell, PhD, Merck
Henrietta Vinnerås, MSc, Fresenius Kabi AB
Glenn Wright, PDA
Earl Zablackis, PhD, Sanofi Pasteur
Steve Zdravkovic, Baxter International Inc.
Qingyu Zeng, PhD, West Pharmaceutical Services, Inc.
PDA, Inc., Leadership
Chair
Susan Schniepp, Regulatory Compliance Associates Inc.
Chair-elect
Anil Sawant, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Treasurer
Melissa Seymour, Biogen, Inc.
Secretary
Emma Ramnarine, Roche Pharma
Immediate Past Chair
Jette Christensen, PhD, Novo Nordisk
Directors
Barbara Allen, PhD, Eli Lilly & Company
Bettine Boltres, West PharmaceuticalServices
Tia Bush, Amgen, Inc.
Javier Camposano, Celltrion
Mirko Gabriele, Thermo Fisher Scientific
Ghada Haddad, PhD, Merck & Co., Inc./Merck Sharp & Dohme
Andrew Hopkins, Abbvie
Stephan Krause, PhD, AstraZeneca Biologics
Amy McDaniel, Bristol Myers Squibb
Mary Oates, PhD, Sanofi Pasteur
Mathias Romacker, (ret.)
Osamu Shirokizawa, Life Scienta Ltd.
PDA Staff Liaisons
Richard Johnson, President & CEO
Walter Morris, Sr. Director, Publishing & Press Relations